Dr. Bill Elliott, PhD (Co-founder) has broad experience in cancer drug discovery and development from his work at Parke-Davis, Molecular Imaging Research, and Karmanos Cancer Institute. Bill cofounded Molecular Imaging Research, which Charles River Laboratories subsequently acquired. Bill serves as Chief Technology Officer.
Current role